XML 63 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Investment in Viking - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2017
Dec. 31, 2018
Apr. 30, 2016
Aug. 31, 2014
Variable Interest Entity [Line Items]            
Loss recorded (as a percent) 12.40%          
Investment in Viking common stock   $ 48,400   $ 46,200    
Warrants   1,500        
Exercise price of warrants (USD per share)           $ 125.08
Warrants investments in Viking   58,335   55,448    
Equity Method Investee            
Variable Interest Entity [Line Items]            
Increase (decrease) in equity method investment     $ 2,700      
Exercise price of warrants (USD per share)         $ 1.50  
Warrants            
Variable Interest Entity [Line Items]            
Warrants investments in Viking   $ 9,900   $ 9,300    
Viking Therapeutics, Inc.            
Variable Interest Entity [Line Items]            
Ownership interest (as a percent)   10.30%